Molecular property diagnostic suite (MPDS): Development of disease-specific open source web portals for drug discoveryFootnote^$

^$Presented at the 9th International Symposium on Computational Methods in Toxicology and Pharmacology Integrating Internet Resources, CMTPI-2017, 27–30 October 2017, Goa, India.

References

• D.B. Searls, Data integration: Challenges for drug discovery, Nat. Rev. Drug Discov. 4 (2005), pp. 45–58.
   PubMed Web of Science ®Google Scholar
• J. Mullen, S.J. Cockell, P. Woollard, and A. Wlpat, An integrated data driven approach to drug repositioning using gene-disease associations, PLoS ONE 11 (2016), p. e0155811.
   PubMed Web of Science ®Google Scholar
• J. Luo, M. Wu, D. Gopukumar, and Y. Zhao, Big data application in biomedical research and health care: A literature review, Biomed. Inform. Insights 8 (2016), pp. 1–10.
   PubMed Web of Science ®Google Scholar
• A. Belle, R. Thiagarajan, S.M.R. Soroushmehr, F. Navidi, D.A. Beard, and K. Najarian, Big data analytics in healthcare, Biomed. Res. Int. 2015 (2015), pp. 1–16.
   Web of Science ®Google Scholar
• A.S. Gaur, A. Bhardwaj, A. Sharma, L. John, M.R. Vivek, N. Tripathi, P.V. Bharatam, R. Kumar, S. Janardhan, A. Mori, A. Banerji, A.M. Lynn, A.J. Hemrom, A. Passi, A. Singh, A. Kumar, C. Muvva, C. Madhuri, C. Choudhury, A.D. Kumar, D. Pandit, D.R. Bharti, D. Kumar, A. Er, G.P.S. Singam, H. Raghava, H. Sailaja, K. Jangra, K. Raithatha, K. Tanneeru, M. Chaudhary, M. Karthikeyan, N. Prasanthi, N. Kumar, N.K. Yedukondalu, P.S. Rajput, P. Saranya, P. Narang, R.V. Dutta, R. Krishnan, R.Srinithi Sharma, R. Mishra S. Hemasri, S. Singh, S. Venkatesan, S. Kumar, U.C.A. Jaleel, V. Khedkar, Y. Joshi, and G.N. Sastry, Assessing therapeutic potential of molecules: Molecular Property Diagnostic Suite for Tuberculosis (MPDSTB), J. Chem. Sci. 129 (2017), pp. 515–531.
   Web of Science ®Google Scholar
• S. Janardhan and G.N. Sastry, Dipeptidyl peptidase IV inhibitors: A new paradigm in type 2 diabetes treatment, Curr. Drug Targets 15 (2014), pp. 600–621.
   PubMed Web of Science ®Google Scholar
• D.E. Scott, A.G. Coyne, S.A. Hudson, and C. Abell, Fragment-based approaches in drug discovery and chemical biology, Biochemistry 51 (2012), pp. 4990–5003.
   PubMed Web of Science ®Google Scholar
• D. Blankenberg, G. Von Kuster, N. Coraor, G. Ananda, R. Lazarus, M. Mangan, A. Nekrutenko, and J. Taylor, Galaxy: A web-based genome analysis tool for experimentalists, Curr. Protoc. Mol. Biol. Chapter 19 Unit 19.10 (2010), pp. 1–21.
   Google Scholar
• E. Afgan, D. Baker, M.V.D. Beek, D. Blankenberg, D. Bouvier, M. Cech, J. Chilton, D. Clements, N. Coraor, C. Eberhard, B. Gruning, A. Guerler, J.H. Jackson, G.V. Kuster, E. Rasche, N. Soranzo, N. Turaga, J. Taylor, A. Nekrutenko, and J. Goecks, The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update, Nucleic Acids Res. 44 (2016), pp. W3–W10.
   PubMedGoogle Scholar
• S. Janardhan, L. John, M. Prasanthi, V. Poroikov, and G.N. Sastry, A QSAR and molecular modelling study towards new lead finding: Polypharmacological approach to Mycobacterium tuberculosis, SAR QSAR Environ. Res. 2017 doi:10.1080/1062936X.2017.1398782.
   PubMedGoogle Scholar
• P.J.A. Goodford, Computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem. 28 (1985), pp. 849–857.
   PubMed Web of Science ®Google Scholar
• A. Miranker and M. Karplus, Functionality maps of binding sites: A multiple copy simultaneous search method, Proteins 11 (1991), pp. 29–34.
   PubMed Web of Science ®Google Scholar
• A. Caflisch, A. Miranker, and M. Karplus, Multiple copy simultaneous search and construction of ligands in binding sites: Application to inhibitors of HIV-1 aspartic proteinase, J. Med. Chem. 36 (1993), pp. 2142–2167.
   PubMed Web of Science ®Google Scholar
• U. Lessel, B. Wellenzohn, M. Lilienthal, and H. Claussen, Searching fragment spaces with feature trees, J. Chem. Inf. Model. 49 (2009), pp. 270–279.
   PubMed Web of Science ®Google Scholar
• R.F. Ludlow, M.L. Verdonk, H.K. Saini, I.J. Tickle, and H. Jhoti, Detection of secondary binding sites in proteins using fragment screening, Proc. Natl. Acad. Sci. 112 (2015), pp. 15910–15915.
   PubMed Web of Science ®Google Scholar
• M. Congreve, R. Carr, C. Murray, and H.A. Jhoti, “Rule of three” for fragment-based lead discovery?, Drug. Discov. Today 8 (2003), pp. 876–877.
   PubMed Web of Science ®Google Scholar
• H. Koster, T. Craan, S. Brass, C. Herhaus, M. Zentgraf, L. Neumann, A. Heine, and G. Klebe, A small non rule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes, J. Med. Chem. 54 (2011), pp. 7784–7796.
   PubMed Web of Science ®Google Scholar
• P. Badrinarayan and G.N. Sastry, Exploiting DFG-out conformation as a strategy to design new type II p38 MAP Kinase leads: Sequence, strategy and active site analysis, J. Chem. Inf. Model. 51 (2011), pp. 115–129.
   PubMed Web of Science ®Google Scholar
• P. Badrinarayan and G.N. Sastry, Virtual screening filters for the design of type II p38 MAP kinase inhibitors: A fragment-based library generation approach, J. Mol. Graph. Model. 34 (2012), pp. 89–100.
   PubMed Web of Science ®Google Scholar
• N.M. O’Boyle, M. Banck, C.A. James, C. Morley, T. Vandermeersch, and G.R. Hutchison, Open Babel: An open chemical toolbox, J. Cheminform. 3 (2011), p,. 33.
   PubMed Web of Science ®Google Scholar
• A.S. Reddy, S.P. Pati, P.P. Kumar, H.N. Pradeep, and G.N. Sastry, Virtual screening in drug discovery – a computational perspective, Curr. Protein. Pept. Sci. 4 (2007), pp. 329–351.
   Google Scholar
• P. Badrinarayan and G.N. Sastry, Virtual high throughput screening in new lead identification, Comb. Chem. High Throughput Screen. 14 (2011), pp. 840–860.
   PubMed Web of Science ®Google Scholar
• A. Lagunin, A. Stepanchikova, D. Filimonov, and V. Poroikov, PASS: Prediction of activity spectra for biologically active substances, Bioinformatics 16 (2000), pp. 747–748.
   PubMed Web of Science ®Google Scholar
• D.A. Filimonov, A.A. Lagunin, T.A. Gloriozova, A.V. Rudik, D.S. Druzhilovskiy, P.V. Pogodin, and V.V. Poroikov, Prediction of the biological activity spectra of organic compounds using the PASS online web resource, Chem. Heterocycl. Compnd. 50 (2014), pp. 444–457.
   Web of Science ®Google Scholar
• T. Rolland, M. Taşan, B. Charloteaux, S.J. Pevzner, Q. Zhong, N. Sahni, S. Yi, I. Lemmens, C. Fontanillo, R. Mosca, A. Kamburov, S.D. Ghiassian, X. Yang, L. Ghamsari, D. Balcha, B.E. Begg, P. Braun, M. Brehme, M.P. Broly, A.R. Carvunis, D. Convery-Zupan, R. Corominas, J. Coulombe-Huntington, E. Dann, M. Dreze, A. Dricot, C. Fan, E. Franzosa, F. Gebreab, B.J. Gutierrez, M.F. Hardy, M. Jin, S. Kang, R. Kiros, G.N. Lin, K. Luck, A. MacWilliams, J. Menche, R.R. Murray, A. Palagi, M.M. Poulin, X. Rambout, J. Rasla, P. Reichert, V. Romero, E. Ruyssinck, J.M. Sahalie, A. Scholz, A.A. Shah, A. Sharma, Y. Shen, K. Spirohn, S. Tam, A.O. Tejeda, S.A. Trigg, J.C. Twizere, K. Vega, J. Walsh, M.E. Cusick, Y. Xia, A.L. Barabási, L.M. Iakoucheva, P. Aloy, J. De Las Rivas, J. Tavernier, M.A. Calderwood, D.E. Hill, T. Hao, F.P. Roth, and M. Vida, A proteome-scale map of the human interactome network, Cell 159 (2014), pp. 1212–1226.
   PubMed Web of Science ®Google Scholar
• L. Hakes, J.W. Pinney, D.L. Robertson, and S.C. Lovell, Protein-protein interaction networks and biology – What’s the connection? Nat. Biotechnol. 26 (2008), pp. 69–72.
   PubMed Web of Science ®Google Scholar
• N. Zmora, S. Bashiardes, M. Levy, and E. Elinav, The role of the immune system in metabolic health and disease, Cell. Metab. 25 (2017), pp. 506–521.
   PubMed Web of Science ®Google Scholar
• B. Chen and A.J. Butte, Leveraging big data to transform target selection and drug discovery, Clin. Pharmacol. Ther. 99 (2017), pp. 285–297.
   Web of Science ®Google Scholar
• W. Raghupathi and V. Raghupathi, Big data analytics in healthcare: Promise and potential, Health. Inf Sci Syst. 2 (2014), pp. 1–10.
   PubMedGoogle Scholar
• S.A. Neymotin and W.W. Lytton, Multiscale modeling for drug discovery in brain disease, Drug Discov Today: Disease 19 (2016), pp. 1–3.
   Google Scholar
• V. Matys, E. Fricke, R. Geffers, E. Gössling, M. Haubrock, R. Hehl, K. Hornischer, D. Karas, A.E. Kel, O.V. Kel-Margoulis, D.U. Kloos, S. Land, B. Lewicki-Potapov, H. Michael, R. Münch, I. Reuter, S. Rotert, H. Saxel, M. Scheer, S. Thiele, and E. Wingender, TRANSFAC: Transcriptional regulation, from patterns to profiles, Nucleic Acids Res. 31 (2003), pp. 374–378.
   PubMed Web of Science ®Google Scholar
• J. Menche, A. Sharma, M. Kitsak, S.D. Ghiassian, M. Vidal, J. Loscalzo, and A-L. Barabasi, Uncovering disease-disease relationships through the incomplete interactome, Science 347 (2015), pp. 1257601–1–1257601-8.
   Web of Science ®Google Scholar
• B. Aranda, P. Achuthan, Y. Alam-Faruque, I. Armean, A. Bridge, C. Derow, M. Feuermann, A.T. Ghanbarian, S. Kerrien, J. Khadake, J. Kerssemakers, C. Leroy, M. Menden, M. Michaut, L. Montecchi-Palazzi, S.N. Neuhauser, S. Orchard, V. Perreau, B. Roechert, K. van Eijk, and H. Hermjakob, The IntAct molecular interaction database in 2010, Nucleic Acids Res. 38 (2010), pp. D525–D531.
   PubMed Web of Science ®Google Scholar
• A. Ceol, A. Chatr Aryamontri, L. Licata, D. Peluso, L. Briganti, L. Perfetto, L. Castagnoli, and G. Cesareni, MINT, the molecular interaction database: 2009 update, Nucleic Acids Res. 38 (2010), pp. D532–D539.
   PubMedGoogle Scholar
• C. Stark, B.J. Breitkreutz, A. Chatr-Aryamontri, L. Boucher, R. Oughtred, M.S. Livstone, J. Nixon, K. Van Auken, X. Wang, X. Shi, T. Reguly, J.M. Rust, A. Winter, K. Dolinski, M. Tyers, The biogrid interaction database: 2011 update, Nucleic Acids Res. 39 (2011), pp. D698–D704.
   PubMed Web of Science ®Google Scholar
• T.S. Keshava Prasad, R. Goel, K. Kandasamy, S. Keerthikumar, S. Kumar, S. Mathivanan, D. Telikicherla, R. Raju, B. Shafreen, A. Venugopal, L. Balakrishnan, A. Marimuthu, S. Banerjee, D.S. Somanathan, A. Sebastian, S. Rani, S. Ray, C.J. Harrys Kishore, S. Kanth, M. Ahmed, M.K. Kashyap, R. Mohmood, Y.L. Ramachandra, V. Krishna, B.A. Rahiman, S. Mohan, P. Ranganathan, S. Ramabadran, R. Chaerkady, and A. Pandey, Human protein reference database – 2009 update, Nucleic Acids Res. 37 (2009), pp. D767–D772.
   PubMed Web of Science ®Google Scholar
• I. Lee, U.M. Blom, P.I. Wang, J.E. Shim, and E.M. Marcotte, Prioritizing candidate disease genes by network-based boosting of genome-wide association data, Genome Res. 21 (2011), pp. 1109–1121.
   PubMed Web of Science ®Google Scholar
• A. Ruepp, B. Waegele, M. Lechner, B. Brauner, I. Dunger-Kaltenbach, G. Fobo, G. Frishman, C. Montrone, and H.W. Mewes, CORUM: The comprehensive resource of mammalian protein complexes—2009, Nucleic Acids Res. 38 (2010), pp. D497–D501.
   PubMed Web of Science ®Google Scholar
• P.V. Hornbeck, J.M. Kornhauser, S. Tkachev, B. Zhang, E. Skrzypek, B. Murray, V. Latham, and M. Sullivan, PhosphoSitePlus: A comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse, Nucleic Acids Res. 40 (2012), pp. D261–D270.
   PubMed Web of Science ®Google Scholar
• A. Vinayagam, U. Stelzl, R. Foulle, S. Plassmann, M. Zenkner, J. Timm, H.E. Assmus, M. A. Andrade-Navarro, and E.E. Wanker, A directed protein interaction network for investigating intracellular signal transduction, Sci. Signal. 4 (2011), pp. rs8.
   Google Scholar
• P.E. Scherer, Adipose tissue: From lipid storage compartment to endocrine organ, Diabetes. 55 (2006), pp. 1537–1545.
   PubMed Web of Science ®Google Scholar
• J. Hirosumi, G. Tuncman, L. Chang, C.Z. Gorgun, K.T. Uysal, K. Maeda, M. Karin, and G.S. Hotamisligil, A central role for JNK in obesity and insulin resistance, Nature 420 (2002), pp. 333–336.
   PubMed Web of Science ®Google Scholar
• N. Ouchi, A. Higuchi, K. Ohashi, Y. Oshima, N. Gokce, R. Shibata, Y. Akasaki, A. Shimono, and K. Walsh, Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity, Science 329 (2010), pp. 454–457.
   PubMed Web of Science ®Google Scholar
• H.J. Kim, T. Higashimori, S.Y. Park, H. Choi, J. Dong, Y.J. Kim, H.L. Noh, Y.R. Cho, G. Cline, Y.B. Kim, J. K. Kim, Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo, Diabetes 53 (2004), pp. 1060–1067.
   PubMed Web of Science ®Google Scholar
• A. Gaffo, K.G. Saag, and J.R. Curtis, Treatment of rheumatoid arthritis, Am. J. Health Syst. Pharm. 63 (2006), pp. 2451–2465.
   PubMed Web of Science ®Google Scholar
• L. Bossaller and A. Rothe, Monoclonal antibody treatments for rheumatoid arthritis, Expert Opin. Biol. Ther. 13 (2013), pp. 1257–1272.
   PubMed Web of Science ®Google Scholar
• A. Gokhale, T.K. Weldeghiorghis, V. Taneja, and S.D. Satyanarayanajois, Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58, J. Med. Chem. 54 (2011), pp. 5307–5319.
   PubMed Web of Science ®Google Scholar
• M. Tsai, M. Grimbaldeston, and S.J. Galli, Mast cells and immunoregulation/immunomodulation, Adv. Exp. Med. Biol. 716 (2011), pp. 186–211.
   PubMed Web of Science ®Google Scholar
• O. Bloom, K.F. Cheng, M. He, A. Papatheodorou, B.T. Volpe, B. Diamond, and Y. Al-Abed, Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity, Proc. Natl Acad. Sci. USA 108 (2011), pp. 10255–10259.
   PubMed Web of Science ®Google Scholar
• P.T. Kaumaya and K.C. Foy, Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy, Future Oncol. 8 (2012), pp. 961–987.
   PubMed Web of Science ®Google Scholar
• P.T. Kaumaya, Bridging oncology and immunology: Expanding horizons with innovative peptide vaccines and peptidomimetics, Immunotherapy 5 (2013), pp. 1159–1163.
   PubMed Web of Science ®Google Scholar
• M.J. Welters, G.G. Kenter, S.J. Piersma, A.P. Vloon, M.J. Löwik, D.M. Berends-van der Meer, J.W. Drijfhout, A.R. Valentijn, A.R. Wafelman, J. Oostendorp, G.J. Fleuren, R. Offringa, C.J. Melief, and S.H. van der Burg, Induction of tumor specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papilloma virus type 16 E6 and E7 long peptides vaccine, Clin. Cancer Res. 14 (2008), pp. 178–187.
   PubMed Web of Science ®Google Scholar
• Z. Hayouka, M. Hurevich, A. Levin, H. Benyamini, A. Iosub, M. Maes, D.E. Shalev, A. Loyter, C. Gilon, and A. Friedler, Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein, Bioorg. Med. Chem. 18 (2010), pp. 8388–8395.
   PubMed Web of Science ®Google Scholar
• L. De Luca, S. Ferro, F. Morreale, and A. Chimirri, Inhibition of the interaction between HIV-1 integrase and its cofactor LEDGF/p75: A promising approach in anti-retroviral therapy, Mini Rev. Med. Chem. 11 (2011), pp. 714–727.
   PubMed Web of Science ®Google Scholar
• A.S. Gokhale and S. Satyanarayanajois, Peptides and peptidomimetics as immunomodulators, Immunotherapy 6 (2014), pp. 755–774.
   PubMed Web of Science ®Google Scholar